115 related articles for article (PubMed ID: 25519022)
1. Evaluation of Annexin A2 as a novel diagnostic serum biomarker for lung cancer.
Yang J; Yang F; Nie J; Zou X; Tian H; Qin Y; Liu C
Cancer Biomark; 2015; 15(2):205-11. PubMed ID: 25519022
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of annexin II as a potential serum marker for hepatocellular carcinoma using a developed sandwich ELISA method.
Ji NY; Park MY; Kang YH; Lee CI; Kim DG; Yeom YI; Jang YJ; Myung PK; Kim JW; Lee HG; Kim JW; Lee K; Song EY
Int J Mol Med; 2009 Dec; 24(6):765-71. PubMed ID: 19885616
[TBL] [Abstract][Full Text] [Related]
3. A sandwich enzyme-linked immunosorbent assay for detection of calreticulin in human serum.
Wu W; Wang G; Tan C; Zou X; Wang Y; Liu C
Monoclon Antib Immunodiagn Immunother; 2013 Oct; 32(5):366-70. PubMed ID: 24111870
[TBL] [Abstract][Full Text] [Related]
4. Circulating annexin A2 as a biomarker in gastric cancer patients: correlation with clinical variables.
Tas F; Tilgen Yasasever C; Karabulut S; Tastekin D; Duranyildiz D
Biomed Pharmacother; 2015 Feb; 69():237-41. PubMed ID: 25661364
[TBL] [Abstract][Full Text] [Related]
5. Serum exosomal-annexin A2 is associated with African-American triple-negative breast cancer and promotes angiogenesis.
Chaudhary P; Gibbs LD; Maji S; Lewis CM; Suzuki S; Vishwanatha JK
Breast Cancer Res; 2020 Jan; 22(1):11. PubMed ID: 31992335
[TBL] [Abstract][Full Text] [Related]
6. Serum Annexin A2 Level Is Associated With Diagnosis and Prognosis in Patients With Oral Squamous Cell Carcinoma.
Zhang W; Gao C; Zhang S; Fang G
J Oral Maxillofac Surg; 2017 May; 75(5):1081-1087. PubMed ID: 27889534
[TBL] [Abstract][Full Text] [Related]
7. Glycosylated Alpha-1-acid glycoprotein 1 as a potential lung cancer serum biomarker.
Ayyub A; Saleem M; Fatima I; Tariq A; Hashmi N; Musharraf SG
Int J Biochem Cell Biol; 2016 Jan; 70():68-75. PubMed ID: 26563422
[TBL] [Abstract][Full Text] [Related]
8. Clinical value of eukaryotic elongation factor 2 (eEF2) in non-small cell lung cancer patients.
Sun HG; Dong XJ; Lu T; Yang MF; Wang XM
Asian Pac J Cancer Prev; 2014 Jan; 14(11):6533-5. PubMed ID: 24377563
[TBL] [Abstract][Full Text] [Related]
9. Identification of serum proteome components associated with progression of non-small cell lung cancer.
Pietrowska M; Jelonek K; Michalak M; Roś M; Rodziewicz P; Chmielewska K; Polański K; Polańska J; Gdowicz-Kłosok A; Giglok M; Suwiński R; Tarnawski R; Dziadziuszko R; Rzyman W; Widłak P
Acta Biochim Pol; 2014; 61(2):325-31. PubMed ID: 24872961
[TBL] [Abstract][Full Text] [Related]
10. Development and clinical evaluation of a multi-purpose mAb and a sandwich ELISA test for hepatoma-derived growth factor in lung cancer patients.
Zhang A; Long W; Guo Z; Liu G; Hu Z; Huang Y; Li Y; Grabinski TM; Yang J; Zhao PX; Everett AD; Zhang Y; Cao BB
J Immunol Methods; 2010 Apr; 355(1-2):61-7. PubMed ID: 20193688
[TBL] [Abstract][Full Text] [Related]
11. Circulating annexin A2 as a biomarker in patients with pancreatic cancer.
Karabulut M; Afsar CU; Serilmez M; Karabulut S
J Cancer Res Ther; 2020 Dec; 16(Supplement):S110-S115. PubMed ID: 33380663
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of annexin A2 and annexin A4 expression in patients with cervical cancer.
Choi CH; Chung JY; Chung EJ; Sears JD; Lee JW; Bae DS; Hewitt SM
BMC Cancer; 2016 Jul; 16():448. PubMed ID: 27402115
[TBL] [Abstract][Full Text] [Related]
13. [OLC1 protein levels in plasma of patients with non-small cell lung cancer and its clinical application].
Yang L; Xiao T; Tan J; Chen S; Gao Y; Cheng S; Liu X; Sun K
Zhonghua Zhong Liu Za Zhi; 2014 May; 36(5):362-5. PubMed ID: 25030592
[TBL] [Abstract][Full Text] [Related]
14. Antibodies against the N-terminal domain of annexin A2 in antiphospholipid syndrome.
Salle V; Mazière JC; Brulé A; Schmidt J; Smail A; Duhaut P; Mazière C; Makdassi R; Choukroun G; Betsou F; Ducroix JP
Eur J Intern Med; 2012 Oct; 23(7):665-8. PubMed ID: 22939813
[TBL] [Abstract][Full Text] [Related]
15. [Detection of plasma cofilin protein for diagnosis of lung cancer].
Zheng Y; Fang Y; Li S; Zheng B
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Oct; 33(10):1551-3. PubMed ID: 24144768
[TBL] [Abstract][Full Text] [Related]
16. Annexin-A2 as predictor biomarker of recurrent disease in endometrial cancer.
Alonso-Alconada L; Santacana M; Garcia-Sanz P; Muinelo-Romay L; Colas E; Mirantes C; Monge M; Cueva J; Oliva E; Soslow RA; Lopez MA; Palacios J; Prat J; Valls J; Krakstad C; Salvesen H; Gil-Moreno A; Lopez-Lopez R; Dolcet X; Moreno-Bueno G; Reventos J; Matias-Guiu X; Abal M
Int J Cancer; 2015 Apr; 136(8):1863-73. PubMed ID: 25219463
[TBL] [Abstract][Full Text] [Related]
17. Cytoskeleton-Associated Protein 4 Is a Novel Serodiagnostic Marker for Lung Cancer.
Yanagita K; Nagashio R; Jiang SX; Kuchitsu Y; Hachimura K; Ichinoe M; Igawa S; Fukuda E; Goshima N; Satoh Y; Murakumo Y; Saegusa M; Sato Y
Am J Pathol; 2018 Jun; 188(6):1328-1333. PubMed ID: 29751934
[TBL] [Abstract][Full Text] [Related]
18. Identification of haptoglobin peptide as a novel serum biomarker for lung squamous cell carcinoma by serum proteome and peptidome profiling.
Okano T; Seike M; Kuribayashi H; Soeno C; Ishii T; Kida K; Gemma A
Int J Oncol; 2016 Mar; 48(3):945-52. PubMed ID: 26783151
[TBL] [Abstract][Full Text] [Related]
19. Serum annexin A2 levels in acute brucellosis and brucellar spondylodiscitis.
Aktug Demir N; Kolgelier S; Sumer S; Inkaya AC; Ozcimen S; Demir LS; Ural O; Arpaci A
Eur J Clin Microbiol Infect Dis; 2014 Oct; 33(10):1855-9. PubMed ID: 24853056
[TBL] [Abstract][Full Text] [Related]
20. Quantitative detection of tumor M2-pyruvate kinase in plasma of patients with lung cancer in comparison to other lung diseases.
Schneider J; Morr H; Velcovsky HG; Weisse G; Eigenbrodt E
Cancer Detect Prev; 2000; 24(6):531-5. PubMed ID: 11198266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]